Tiange Wu

87 Dingjia Bridge Hunan Road
Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

ZNF263-NuRD-mediated repression of STAT1 curtails MHC-I antigen presentation and IFN-γ efficacy in prostate cancer.

ZNF263-NuRD-mediated repression of STAT1 curtails MHC-I antigen presentation and IFN-γ efficacy in prostate cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 21, 2026

HOXD11-NMDAR signaling drives neuroendocrine prostate cancer and enables potential therapeutic intervention as a target of memantine.

HOXD11-NMDAR signaling drives neuroendocrine prostate cancer and enables potential therapeutic intervention as a target of memantine.

Journal: Cell reports

Published: December 16, 2025

Multi-omics analyses related to unfolded protein response in prostate cancer implicate pro-tumor role of IFRD1.

Multi-omics analyses related to unfolded protein response in prostate cancer implicate pro-tumor role of IFRD1.

Journal: Frontiers in immunology

Published: November 11, 2025

A conserved eIF1A+ luminal cell-centered hypoxic and "cold" tumor microenvironment promotes pan-subtype prostate cancer progression.

A conserved eIF1A+ luminal cell-centered hypoxic and "cold" tumor microenvironment promotes pan-subtype prostate cancer progression.

Journal: Cell reports. Medicine

Published: August 26, 2025

Remote ischemia precondition protects against renal IRI through apoptosis associated vesicles carrying MIF protein via modulating DUSP6/JNK signaling axis.

Remote ischemia precondition protects against renal IRI through apoptosis associated vesicles carrying MIF protein via modulating DUSP6/JNK signaling axis.

Journal: Journal of nanobiotechnology

Published: January 20, 2025

Comparing oncologic outcomes of partial and radical nephrectomy for T2 renal cell carcinoma: a propensity score matching cohort study and an external multicenter validation.

Comparing oncologic outcomes of partial and radical nephrectomy for T2 renal cell carcinoma: a propensity score matching cohort study and an external multicenter validation.

Journal: World journal of urology

Published: November 27, 2024

Matrix Metalloproteinase-9 is associated with tumor microenvironment remodeling of bladder cancer.

Matrix Metalloproteinase-9 is associated with tumor microenvironment remodeling of bladder cancer.

Journal: Biology direct

Published: September 24, 2024

YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice.

YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice.

Journal: Nature communications

Published: July 24, 2024

Correction: Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer.

Correction: Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer.

Journal: European journal of medical research

Published: June 02, 2024

MDK promotes M2 macrophage polarization to remodel the tumour microenvironment in clear cell renal cell carcinoma.

MDK promotes M2 macrophage polarization to remodel the tumour microenvironment in clear cell renal cell carcinoma.

Journal: Scientific reports

Published: April 14, 2024

Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer.

Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer.

Journal: European journal of medical research

Published: March 02, 2024

YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6.

YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6.

Journal: Journal for immunotherapy of cancer

Published: March 27, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026